215 related articles for article (PubMed ID: 35978661)
1. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity.
Sahu T; Pande B; Pl M; Verma HK
World J Hepatol; 2022 Jun; 14(6):1099-1110. PubMed ID: 35978661
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
4. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
[TBL] [Abstract][Full Text] [Related]
5. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
6. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease.
Gurala D; Al Moussawi H; Philipose J; Abergel JR
Cureus; 2020 Aug; 12(8):e10045. PubMed ID: 32983735
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
9. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19.
Wong GL; Yip TC; Wong VW; Tse YK; Hui DS; Lee SS; Yeoh EK; Chan HL; Lui GC
Open Forum Infect Dis; 2021 Jun; 8(6):ofab205. PubMed ID: 34099979
[TBL] [Abstract][Full Text] [Related]
11. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
[TBL] [Abstract][Full Text] [Related]
12. Liver dysfunction and SARS-CoV-2 infection.
Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
[TBL] [Abstract][Full Text] [Related]
13. Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective.
Hanif FM; Majid Z; Ahmed S; Luck NH; Mubarak M
World J Virol; 2022 Nov; 11(6):453-466. PubMed ID: 36483109
[TBL] [Abstract][Full Text] [Related]
14. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.
Suess C; Hausmann R
Int J Legal Med; 2020 Jul; 134(4):1285-1290. PubMed ID: 32504146
[TBL] [Abstract][Full Text] [Related]
15. Liver damage at admission is an independent prognostic factor for COVID-19.
Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
[TBL] [Abstract][Full Text] [Related]
16. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
Zawilska JB; Lagodzinski A; Berezinska M
J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Gastrointestinal Symptoms, Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection: An Early Experience.
Hasel K; Salim A; Verma S; D'Adamo C; Arrup D; Vinayek R; Dutta SK
Cureus; 2022 Feb; 14(2):e22152. PubMed ID: 35308711
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence.
Idalsoaga F; Ayares G; Arab JP; Díaz LA
J Clin Transl Hepatol; 2021 Oct; 9(5):760-768. PubMed ID: 34722191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
